BACKGROUND: Antipyretics reduce the prolonged, high fever characteristic of typhoid fever. The benefits of nonsteroidal drugs in this role have not been quantified. There have been concerns about the safety of antipyretics in typhoid. METHODS: In a double blind randomized study, 80 Vietnamese children with uncomplicated typhoid fever were randomized to receive identical syrup preparations of ibuprofen (10 mg/kg) or paracetamol (12 mg/kg) every 6 h until 36 h after defervescence. Children with a nalidixic acid-susceptible (Na) isolate of Salmonella typhi were treated with ofloxacin (15 mg/kg/day) for 3 days and those with a nalidixic acid-resistant (Na) isolate were treated for 7 days. RESULTS: S. typhi was isolated from 36 of 40 children randomized to ibuprofen (11 isolates Na) and 37 of 40 randomized to paracetamol (13 isolates Na). The median (range) fever clearance time (hours) was shorter in the ibuprofen group than the paracetamol group (68, 4 to 260 vs. 104, 12 to 404; P = 0.055) as was the area under the temperature time curve above 37 degree C (74, 0 to 237 vs. 127, 0 to 573; P = 0.013). The differences occurred predominantly in the children infected with a NaS. typhi whose infections responded more slowly to antibiotic treatment. There were no major side effects associated with the use of either drug. There were no differences between the two treatment arms in the concentrations of circulating interleukin-6 and tumor necrosis factor alpha during the course of treatment. CONCLUSION: The antipyretic effect of ibuprofen is superior to that of paracetamol in children with typhoid fever, particularly those with prolonged fever. Both antipyretics appeared to be safe.
RCT Entities:
BACKGROUND: Antipyretics reduce the prolonged, high fever characteristic of typhoid fever. The benefits of nonsteroidal drugs in this role have not been quantified. There have been concerns about the safety of antipyretics in typhoid. METHODS: In a double blind randomized study, 80 Vietnamese children with uncomplicated typhoid fever were randomized to receive identical syrup preparations of ibuprofen (10 mg/kg) or paracetamol (12 mg/kg) every 6 h until 36 h after defervescence. Children with a nalidixic acid-susceptible (Na) isolate of Salmonella typhi were treated with ofloxacin (15 mg/kg/day) for 3 days and those with a nalidixic acid-resistant (Na) isolate were treated for 7 days. RESULTS:S. typhi was isolated from 36 of 40 children randomized to ibuprofen (11 isolates Na) and 37 of 40 randomized to paracetamol (13 isolates Na). The median (range) fever clearance time (hours) was shorter in the ibuprofen group than the paracetamol group (68, 4 to 260 vs. 104, 12 to 404; P = 0.055) as was the area under the temperature time curve above 37 degree C (74, 0 to 237 vs. 127, 0 to 573; P = 0.013). The differences occurred predominantly in the children infected with a NaS. typhi whose infections responded more slowly to antibiotic treatment. There were no major side effects associated with the use of either drug. There were no differences between the two treatment arms in the concentrations of circulating interleukin-6 and tumor necrosis factor alpha during the course of treatment. CONCLUSION: The antipyretic effect of ibuprofen is superior to that of paracetamol in children with typhoid fever, particularly those with prolonged fever. Both antipyretics appeared to be safe.
Authors: Monica I Alvarez; Luke C Glover; Peter Luo; Liuyang Wang; Elizabeth Theusch; Stefan H Oehlers; Eric M Walton; Trinh Thi Bich Tram; Yu-Lin Kuang; Jerome I Rotter; Colleen M McClean; Nguyen Tran Chinh; Marisa W Medina; David M Tobin; Sarah J Dunstan; Dennis C Ko Journal: Proc Natl Acad Sci U S A Date: 2017-08-21 Impact factor: 11.205
Authors: Sarah J Dunstan; Nguyen Thi Hue; Buhm Han; Zheng Li; Trinh Thi Bich Tram; Kar Seng Sim; Christopher M Parry; Nguyen Tran Chinh; Ha Vinh; Nguyen Phu Huong Lan; Nga Tran Vu Thieu; Phat Voong Vinh; Samir Koirala; Sabina Dongol; Amit Arjyal; Abhilasha Karkey; Olita Shilpakar; Christiane Dolecek; Jia Nee Foo; Le Thi Phuong; Mai Ngoc Lanh; Tan Do; Tin Aung; Do Nu Hon; Yik Ying Teo; Martin L Hibberd; Katherine L Anders; Yukinori Okada; Soumya Raychaudhuri; Cameron P Simmons; Stephen Baker; Paul I W de Bakker; Buddha Basnyat; Tran Tinh Hien; Jeremy J Farrar; Chiea Chuen Khor Journal: Nat Genet Date: 2014-11-10 Impact factor: 38.330
Authors: Tran Thuy Chau; James Ian Campbell; Claudia M Galindo; Nguyen Van Minh Hoang; To Song Diep; Tran Thu Thi Nga; Nguyen Van Vinh Chau; Phung Quoc Tuan; Anne Laure Page; R Leon Ochiai; Constance Schultsz; John Wain; Zulfiqar A Bhutta; Christopher M Parry; Sujit K Bhattacharya; Shanta Dutta; Magdarina Agtini; Baiqing Dong; Yang Honghui; Dang Duc Anh; Do Gia Canh; Aliya Naheed; M John Albert; Rattanaphone Phetsouvanh; Paul N Newton; Buddha Basnyat; Amit Arjyal; Tran Thi Phi La; Nguyen Ngoc Rang; Le Thi Phuong; Phan Van Be Bay; Lorenz von Seidlein; Gordon Dougan; John D Clemens; Ha Vinh; Tran Tinh Hien; Nguyen Tran Chinh; Camilo J Acosta; Jeremy Farrar; Christiane Dolecek Journal: Antimicrob Agents Chemother Date: 2007-10-01 Impact factor: 5.191
Authors: Jasmine Cendejas-Hernandez; Joshua T Sarafian; Victoria G Lawton; Antara Palkar; Lauren G Anderson; Vincent Larivière; William Parker Journal: Eur J Pediatr Date: 2022-02-17 Impact factor: 3.860
Authors: Moses B Chilombe; Michael P McDermott; Karl B Seydel; Manoj Mathews; Musaku Mwenechanya; Gretchen L Birbeck Journal: PLoS One Date: 2022-10-07 Impact factor: 3.752
Authors: Christopher M Parry; Corinne Thompson; Ha Vinh; Nguyen Tran Chinh; Le Thi Phuong; Vo Anh Ho; Tran Tinh Hien; John Wain; Jeremy J Farrar; Stephen Baker Journal: BMC Infect Dis Date: 2014-02-10 Impact factor: 3.090